Search

Search Results
Results 73191 - 73200 of 90460 for cancer
  • Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Vidaza intended for persons living in Australia.
  • News - 5 May 2026
    A new research paper was published in Volume 18 of Aging-US on April 13, 2026, titled "Cross species activity of TERT human telomerase component."
  • Drug - 4 May 2026
    Consumer Medicine Information (CMI) about Revestive intended for persons living in Australia.
  • News - 28 Apr 2026
    Whenever there is a wound or infection, the body produces an inflammatory response. This is the body's first line of defense, and macrophages — cells of the innate immune system — play a key role:...
  • News - 21 Apr 2026
    As the authors detail, PNI is a prevalent neurological condition that often causes permanent sensory and motor dysfunction, severely impairing patient's quality of life.
  • Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Karvezide intended for persons living in Australia.
  • Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Avapro HCT intended for persons living in Australia.
  • News - 16 Apr 2026
    Efforts to identify and evaluate next-generation therapeutics for pediatric brain tumors are easily stymied by the quality and availability of laboratory models for research. To address this issue,...
  • Drug - 16 Apr 2026
    Consumer Medicine Information (CMI) about Opdualag intended for persons living in Australia.
  • News - 9 Apr 2026
    Published on April 01, 2026, in Volume 2, article number 19 of the journal Immunity & Inflammation, a collaborative team led by Prof. Cao at the Institute of Basic Medical Sciences, Chinese Academy of...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.